Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01471691
What this trial is testing

Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab

Who this might be right for
Branch Retinal Vein OcclusionCentral Retinal Vein OcclusionMacular Edema
Hanscom, Thomas, M.D. 14
Large-scale testing (Phase 3)Study completedNCT00100009
What this trial is testing

Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 30
Testing effectiveness (Phase 2)UnknownNCT02590692
What this trial is testing

Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

Who this might be right for
Dry Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 16
Not applicableStudy completedNCT00539734
What this trial is testing

Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Prince of Songkla University 25
Early research (Phase 1)Study completedNCT04782271
What this trial is testing

Safety, Tolerability and Pharmacokinetic Profile of SYL1801 Eye Drops

Who this might be right for
Safety, Tolerability and Pharmacokinetic Profile in Healthy VolunteersChoroidal Neovascularization
Sylentis, S.A. 36
Not applicableStudy completedNCT00478530
What this trial is testing

The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram

Who this might be right for
Macular Degeneration
Sheba Medical Center 20
Post-approval studies (Phase 4)UnknownNCT02681783
What this trial is testing

PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept

Who this might be right for
Central Serous ChorioretinopathyAge Related Macular DegenerationIdiopathic Poplypoidal Choroidal Vasculopathy
Sunnybrook Health Sciences Centre 90
Large-scale testing (Phase 3)WithdrawnNCT04697953
What this trial is testing

Efficacy and Safety of Brolucizumab 6mg in a Treat and Extend Regimen in Patients With Neovascular Age-Related Macular Degeneration (nAMD) With Prior Anti-VEGF Exposure (PEREGRINE)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals
Not applicableStudy completedNCT00347451
What this trial is testing

Optical Coherence Tomography Imaging of the Posterior Segment in High Myopia.

Who this might be right for
MyopiaMaculopathyGlaucoma
Singapore National Eye Centre 150
Testing effectiveness (Phase 2)UnknownNCT04564937
What this trial is testing

The Study of Drug SCT510A in Patients With Wet Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Sinocelltech Ltd. 66
Not applicableUnknownNCT06262737
What this trial is testing

Single-center Study Measuring OSDI Dry Eye Score in Patients Undergoing an Anti-VEGF Induction Protocol

Who this might be right for
Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
University Hospital, Clermont-Ferrand 50
Not applicableUnknownNCT04627402
What this trial is testing

Effects of Adding Triamcinolone Acetonide to Conbercept Treatment for Refractory Diabetic Macular Edema (CONTE)

Who this might be right for
Diabetes Mellitus, Type 2Macular Edema
Zhongshan Ophthalmic Center, Sun Yat-sen University 50
Not applicableStudy completedNCT00401713
What this trial is testing

Transplantation of Autologous RPE Versus Translocation of Autologous RPE and Choroid in AMD

Who this might be right for
Age-Related Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 40
Not applicableStudy completedNCT02422160
What this trial is testing

Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Stanford University 28
Not applicableEnded earlyNCT04276610
What this trial is testing

Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning?

Who this might be right for
Age-related Macular DegenerationDementiaLow Vision+4 more
Université de Montréal 38
Not applicableUnknownNCT01608113
What this trial is testing

Long-term Follow-up of Subfoveal Neovascular AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Medical University of Vienna 70
Post-approval studies (Phase 4)Study completedNCT01453920
What this trial is testing

Wet AMD Recurrence Rate in Patients Stable on Three Month Ranibizumab Dosing

Who this might be right for
Age Related Macular Degeneration
University Health Network, Toronto 44
Large-scale testing (Phase 3)UnknownNCT03609307
What this trial is testing

Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial

Who this might be right for
Age Related Macular Degeneration
Shahid Beheshti University of Medical Sciences 40
Post-approval studies (Phase 4)Ended earlyNCT00423189
What this trial is testing

Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
David M. Brown, M.D. 7
Not applicableStudy completedNCT01648660
What this trial is testing

Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation for Two More Years (LUTEGA 2)

Who this might be right for
Age Related Maculopathy
University of Jena 80
Next Page